← back to database
SOSV SF and NY (formerly IndieBio) are SOSV's lab-based pre-seed programs for scientist-founders, rebranded in 2026 to reflect a broader deep-tech mandate spanning biology, chemistry, physics, and AI rather than biotech alone. Through 'First Check in Deep Tech,' SOSV invests up to $550K on a SAFE at the earliest stage, then backs winners through later rounds with follow-on capital (60% of its $306M Fund V is reserved for follow-ons), co-investing alongside firms like Khosla Ventures, Sequoia, and Y Combinator. Since 2015 the San Francisco program alone has graduated 310+ companies that have collectively raised $3.6B.
Primary stage
Initial check size
Investment focus
Investment style
Specialist
Data last enriched
Aug 14, 2026
Investing team
- Po BronsonGeneral Partner & Managing Director, SOSV SF
- Stephen ChambersGeneral Partner & Managing Director, SOSV NY
How to reach them
Notable investments
Cayuga Biotech, Hoofprint Biome, Puna Bio, Afynia, Proton Intelligence